Plasmodium infection reduces the volume of the viral reservoir in SIV-infected rhesus macaques receiving antiretroviral therapy

Retrovirology

Volumn 11, Issue 1, 2014, Pages

  Zhan, Xiao Yong ^a   Wang, Nina ^a   Liu, Guangjie ^a   Qin, Limei ^a   Xu, Wanwan ^a   Zhao, Siting ^a   Qin, Li ^a   Chen, Xiaoping ^a  

^a GUANGZHOU INSTITUTES OF BIOMEDICINE AND HEALTH   (China)

Author keywords

AIDS; ART; Co infection; HIV 1; Malaria; Plasmodium; Rhesus macaque model; SIV; Viral reservoir

Indexed keywords

CD38 ANTIGEN; EMTRICITABINE; HLA DR ANTIGEN; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INTERLEUKIN 2; INTERLEUKIN 6; INTERLEUKIN 7; LIPOCORTIN 5; NEOPTERIN; RALTEGRAVIR; TENOFOVIR; TUMOR NECROSIS FACTOR ALPHA; VIRUS DNA; ANTIRETROVIRUS AGENT;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; APOPTOSIS; ARTICLE; CD4+ T LYMPHOCYTE; CONTROLLED STUDY; CORRELATION ANALYSIS; HIGHLY ACTIVE ANTIRETROVIRAL THERAPY; HISTONE ACETYLATION; HUMAN IMMUNODEFICIENCY VIRUS 1; IN VITRO STUDY; IN VIVO STUDY; MALARIA; MEMORY CD4+ T LYMPHOCYTE; MEMORY T LYMPHOCYTE; NONHUMAN; PERIPHERAL BLOOD MONONUCLEAR CELL; PLASMODIUM CYNOMOLGI INFECTION; PROTEIN BLOOD LEVEL; PROTEIN EXPRESSION; RHESUS MONKEY; SIGNAL TRANSDUCTION; SIMIAN ACQUIRED IMMUNODEFICIENCY SYNDROME; T LYMPHOCYTE ACTIVATION; TRANSCRIPTION INITIATION; VIRUS LOAD; VIRUS REACTIVATION; VIRUS REPLICATION; ANIMAL; COMPLICATION; IMMUNOLOGY; ISOLATION AND PURIFICATION; MONONUCLEAR CELL; SIMIAN IMMUNODEFICIENCY VIRUS; VIROLOGY;

HUMAN IMMUNODEFICIENCY VIRUS 1; MACACA MULATTA; REPLICATION COMPETENT VIRUSES; SIMIAN IMMUNODEFICIENCY VIRUS;

ANIMALS; ANTI-RETROVIRAL AGENTS; CD4-POSITIVE T-LYMPHOCYTES; LEUKOCYTES, MONONUCLEAR; MACACA MULATTA; MALARIA; SIMIAN ACQUIRED IMMUNODEFICIENCY SYNDROME; SIMIAN IMMUNODEFICIENCY VIRUS; VIRAL LOAD;

EID: 84924151128     PISSN: None     EISSN: 17424690     Source Type: Journal    
DOI: 10.1186/s12977-014-0112-x     Document Type: Article

References (57)

1. WHO Joint United Nations Program on HIV/AIDS (UNAIDS): UNAIDS report on the global AIDS epidemic in 2013. http://www.unaids.org/en/media/unaids/contentassets/documents/epidemiology/2013/gr2013/UNAIDS_Global_Report_2013_en.pdf.
2. Chomont N, El-Far M, Ancuta P, Trautmann L, Procopio FA, Yassine-Diab B, Boucher G, Boulassel MR, Ghattas G, Brenchley JM, Schacker TW, Hill BJ, Douek DC, Routy JP, Haddad EK, Sekaly RP: HIV reservoir size and persistence are driven by T cell survival and homeostatic proliferation. Nat Med 2009, 15:893-900.
3. Combadiere B, Boissonnas A, Carcelain G, Lefranc E, Samri A, Bricaire F, Debre P, Autran B: Distinct time effects of vaccination on long-term proliferative and IFN-gamma-producing T cell memory to smallpox in humans. J Exp Med 2004, 199:1585-1593.
4. Shan L, Deng K, Shroff NS, Durand CM, Rabi SA, Yang HC, Zhang H, Margolick JB, Blankson JN, Siliciano RF: Stimulation of HIV-1-specific cytolytic T lymphocytes facilitates elimination of latent viral reservoir after virus reactivation. Immunity 2012, 36:491-501.
5. Stevenson MM, Riley EM: Innate immunity to malaria. Nat Rev Immunol 2004, 4:169-180.
6. Chandele A, Mukerjee P, Das G, Ahmed R, Chauhan VS: Phenotypic and functional profiling of malaria-induced CD8 and CD4 T cells during blood-stage infection with Plasmodium yoelii. Immunology 2011, 132:273-286.
7. Li Q, Ruan Z, Zhang H, Peng N, Zhao S, Qin L, Chen X: Characterization of peripheral blood T lymphocyte subsets in Chinese rhesus macaques with repeated or long-term infection with Plasmodium cynomolgi. Parasitol Res 2012, 110:961-969.
8. Miyakoda M, Kimura D, Yuda M, Chinzei Y, Shibata Y, Honma K, Yui K: Malaria-specific and nonspecific activation of CD8+ T cells during blood stage of Plasmodium berghei infection. J Immunol 2008, 181:1420-1428.
9. Kublin JG, Patnaik P, Jere CS, Miller WC, Hoffman IF, Chimbiya N, Pendame R, Taylor TE, Molyneux ME: Effect of Plasmodium falciparum malaria on concentration of HIV-1-RNA in the blood of adults in rural Malawi: a prospective cohort study. Lancet 2005, 365:233-240.
10. Kamya MR, Gasasira AF, Yeka A, Bakyaita N, Nsobya SL, Francis D, Rosenthal PJ, Dorsey G, Havlir D: Effect of HIV-1 infection on antimalarial treatment outcomes in Uganda: A population-based study. J Infect Dis 2006, 193:9-15.
11. Orlov M, Vaida F, Finney OC, Smith DM, Talley AK, Wang R, Kappe SH, Deng Q, Schooley RT, Duffy PE: P. falciparum enhances HIV replication in an experimental malaria challenge system. PLoS One 2012, 7:e39000.
12. Abu-Raddad LJ, Patnaik P, Kublin JG: Dual infection with HIV and malaria fuels the spread of both diseases in sub-Saharan Africa. Science 2006, 314:1603-1606.
13. Froebel K, Howard W, Schafer JR, Howie F, Whitworth J, Kaleebu P, Brown AL, Riley E: Activation by malaria antigens renders mononuclear cells susceptible to HIV infection and re-activates replication of endogenous HIV in cells from HIV-infected adults. Parasite Immunol 2004, 26:213-217.
14. Hoffman IF, Jere CS, Taylor TE, Munthali P, Dyer JR, Wirima JJ, Rogerson SJ, Kumwenda N, Eron JJ, Fiscus SA, Chakraborty H, Taha TE, Cohen MS, Molyneux ME: The effect of Plasmodium falciparum malaria on HIV-1 RNA blood plasma concentration. AIDS 1999, 13:487-494.
15. Chen S, Lai C, Wu X, Lu Y, Han D, Guo W, Fu L, Andrieu JM, Lu W: Variability of bio-clinical parameters in Chinese-origin Rhesus macaques infected with simian immunodeficiency virus: a nonhuman primate AIDS model. PLoS One 2011, 6:e23177.
16. Lewis MG, DaFonseca S, Chomont N, Palamara AT, Tardugno M, Mai A, Collins M, Wagner WL, Yalley-Ogunro J, Greenhouse J, Chirullo B, Norelli S, Garaci E, Savarino A: Gold drug auranofin restricts the viral reservoir in the monkey AIDS model and induces containment of viral load following ART suspension. AIDS 2011, 25:1347-1356.
17. Pitcher CJ, Hagen SI, Walker JM, Lum R, Mitchell BL, Maino VC, Axthelm MK, Picker LJ: Development and homeostasis of T cell memory in rhesus macaque. J Immunol 2002, 168:29-43.
18. Chun TW, Engel D, Mizell SB, Ehler LA, Fauci AS: Induction of HIV-1 replication in latently infected CD4+ T cells using a combination of cytokines. J Exp Med 1998, 188:83-91.
19. Chun TW, Engel D, Mizell SB, Hallahan CW, Fischette M, Park S, Davey RT Jr, Dybul M, Kovacs JA, Metcalf JA, Mican JM, Berrey MM, Corey L, Lane HC, Fauci AS: Effect of interleukin-2 on the pool of latently infected, resting CD4+ T cells in HIV-1-infected patients receiving highly active anti-retroviral therapy. Nat Med 1999, 5:651-655.
20. Wang FX, Xu Y, Sullivan J, Souder E, Argyris EG, Acheampong EA, Fisher J, Sierra M, Thomson MM, Najera R, Frank I, Kulkosky J, Pomerantz RJ, Nunnari G: IL-7 is a potent and proviral strain-specific inducer of latent HIV-1 cellular reservoirs of infected individuals on virally suppressive HAART. J Clin Invest 2005, 115:128-137.
21. Hoshino S, Konishi M, Mori M, Shimura M, Nishitani C, Kuroki Y, Koyanagi Y, Kano S, Itabe H, Ishizaka Y: HIV-1 Vpr induces TLR4/MyD88-mediated IL-6 production and reactivates viral production from latency. J Leukoc Biol 2010, 87:1133-1143.
22. Messele T, Abdulkadir M, Fontanet AL, Petros B, Hamann D, Koot M, Roos MT, Schellekens PT, Miedema F, Rinke de Wit TF: Reduced naive and increased activated CD4 and CD8 cells in healthy adult Ethiopians compared with their Dutch counterparts. Clin Exp Immunol 1999, 115:443-450.
23. Clerici MBS, Lukwiya M, Saresella M, Declich S, Trabattoni D, Pastori CPS, Fracasso C, Fabiani M, Ferrante P, Rizzardini G, Lopalco L: Immune activation in africa is environmentally-driven and is associated with upregulation of CCR5. Italian-Ugandan AIDS Project. AIDS 2000, 14:2083-2092.
24. Archin NM, Keedy KS, Espeseth A, Dang H, Hazuda DJ, Margolis DM: Expression of latent human immunodeficiency type 1 is induced by novel and selective histone deacetylase inhibitors. AIDS 2009, 23:1799-1806.
25. Archin NM, Liberty AL, Kashuba AD, Choudhary SK, Kuruc JD, Crooks AM, Parker DC, Anderson EM, Kearney MF, Strain MC, Richman DD, Hudgens MG, Bosch RJ, Coffin JM, Eron JJ, Hazuda DJ, Margolis DM: Administration of vorinostat disrupts HIV-1 latency in patients on antiretroviral therapy. Nature 2012, 487:482-485.
26. Williams SA, Chen LF, Kwon H, Fenard D, Bisgrove D, Verdin E, Greene WC: Prostratin antagonizes HIV latency by activating NF-kappa B. J Biol Chem 2004, 279:42008-42017.
27. Chan JK, Greene WC: Dynamic roles for NF-kappaB in HTLV-I and HIV-1 retroviral pathogenesis. Immunol Rev 2012, 246:286-310.
28. Haase AT: Targeting early infection to prevent HIV-1 mucosal transmission. Nature 2010, 464:217-223.
29. Apetrei C, Pandrea I, Mellors JW: Nonhuman primate models for HIV cure research. Plos Pathog 2012, 8:e1002892.
30. Dinoso JB, Rabi SA, Blankson JN, Gama L, Mankowski JL, Siliciano RF, Zink MC, Clements JE: A simian immunodeficiency virus-infected macaque model to study viral reservoirs that persist during highly active antiretroviral therapy. J Virol 2009, 83:9247-9257.
31. Chen HY, Di Mascio M, Perelson AS, Ho DD, Zhang L: Determination of virus burst size in vivo using a single-cycle SIV in rhesus macaques. Proc Natl Acad Sci U S A 2007, 104:19079-19084.
32. Smith SM, Holland B, Russo C, Dailey PJ, Marx PA, Connor RI: Retrospective analysis of viral load and SIV antibody responses in rhesus macaques infected with pathogenic SIV: predictive value for disease progression. AIDS Res Hum Retroviruses 1999, 15:1691-1701.
33. Zhou Y, Bao R, Haigwood NL, Persidsky Y, Ho WZ: SIV infection of rhesus macaques of Chinese origin: a suitable model for HIV infection in humans. Retrovirology 2013, 10:89.
34. Ling B, Veazey RS, Luckay A, Penedo C, Xu K, Lifson JD, Marx PA: SIV(mac) pathogenesis in rhesus macaques of Chinese and Indian origin compared with primary HIV infections in humans. AIDS 2002, 16:1489-1496.
35. Coatney GR, Collins WE, Warren M, Contacos PG: The Primate Malarias. Atlanta, GA: CDC, Division of Parasitic Diseases; 1971.
36. Brown AE, Webster HK, Teja-Isavadharm P, Keeratithakul D: Macrophage activation in falciparum malaria as measured by neopterin and interferon-gamma. Clin Exp Immunol 1990, 82:97-101.
37. van der Sluis RM, van Montfort T, Pollakis G, Sanders RW, Speijer D, Berkhout B, Jeeninga RE: Dendritic cell-induced activation of latent HIV-1 provirus in actively proliferating primary T lymphocytes. Plos Pathog 2013, 9:e1003259.
38. Budd RC: Activation-induced cell death. Curr Opin Immunol 2001, 13:356-362.
39. Alimonti JB, Ball TB, Fowke KR: Mechanisms of CD4+ T lymphocyte cell death in human immunodeficiency virus infection and AIDS. J Gen Virol 2003, 84:1649-1661.
40. Toure-Bolde ASJ, Aribot GM, Trape J, Rogier C, Roussilhon C: P. falciparum induced apoptosis in human mononuclear cells. Infect Immunol 1996, 64:744-750.
41. Van Parijs L, Abbas AK: Homeostasis and self-tolerance in the immune system: turning lymphocytes off. Science 1998, 280:243-248.
42. Van Lint C, Emiliani S, Ott M, Verdin E: Transcriptional activation and chromatin remodeling of the HIV-1 promoter in response to histone acetylation. EMBO J 1996, 15:1112-1120.
43. Punsawad C, Krudsood S, Maneerat Y, Chaisri U, Tangpukdee N, Pongponratn E, Nantavisai K, Udomsangpetch R, Viriyavejakul P: Activation of nuclear factor kappa B in peripheral blood mononuclear cells from malaria patients. Malar J 2012, 11:191.
44. Smith SM: Valproic acid and HIV-1 latency: beyond the sound bite. Retrovirology 2005, 2:56.
45. Aguilera O, Fernandez AF, Munoz A, Fraga MF: Epigenetics and environment: a complex relationship. J Appl Physiol 2010, 109:243-251.
46. Sinclair KD, Allegrucci C, Singh R, Gardner DS, Sebastian S, Bispham J, Thurston A, Huntley JF, Rees WD, Maloney CA, Lea RG, Craigon J, McEvoy TG, Young LE: DNA methylation, insulin resistance, and blood pressure in offspring determined by maternal periconceptional B vitamin and methionine status. Proc Natl Acad Sci U S A 2007, 104:19351-19356.
47. Ehrhardt H, Wachter F, Grunert M, Jeremias I: Cell cycle-arrested tumor cells exhibit increased sensitivity towards TRAIL-induced apoptosis. Cell Death Dis 2013, 4:e661.
48. Reddel RR, Murphy LC, Hall RE, Sutherland RL: Differential sensitivity of human breast cancer cell lines to the growth-inhibitory effects of tamoxifen. Cancer Res 1985, 45:1525-1531.
49. Chun TW, Justement JS, Murray D, Hallahan CW, Maenza J, Collier AC, Sheth PM, Kaul R, Ostrowski M, Moir S, Kovacs C, Fauci AS: Rebound of plasma viremia following cessation of antiretroviral therapy despite profoundly low levels of HIV reservoir: implications for eradication. AIDS 2010, 24:2803-2808.
50. Jiang B, Qin L, Du YH, Peng NZ, Chen L, Chen ZW, Chen XP: Transgenic Plasmodium that expresses HIV-1 Gag elicits immunity and protects mice against vaccinia virus-gag and malarial parasites. Vaccine 2010, 28:7915-7922.
51. Suryanarayana K, Wiltrout TA, Vasquez GM, Hirsch VM, Lifson JD: Plasma SIV RNA viral load determination by real-time quantification of product generation in reverse transcriptase-polymerase chain reaction. AIDS Res Hum Retroviruses 1998, 14:183-189.
52. Hofmann-Lehmann R, Swenerton RK, Liska V, Leutenegger CM, Lutz H, McClure HM, Ruprecht RM: Sensitive and robust one-tube real-time reverse transcriptase-polymerase chain reaction to quantify SIV RNA load: comparison of one- versus two-enzyme systems. AIDS Res Hum Retroviruses 2000, 16:1247-1257.
53. Yamamoto N, Tanaka C, Wu Y, Chang MO, Inagaki Y, Saito Y, Naito T, Ogasawara H, Sekigawa I, Hayashida Y: Analysis of human immunodeficiency virus type 1 integration by using a specific, sensitive and quantitative assay based on real-time polymerase chain reaction. Virus Genes 2006, 32:105-113.
54. Shen A, Zink MC, Mankowski JL, Chadwick K, Margolick JB, Carruth LM, Li M, Clements JE, Siliciano RF: Resting CD4+ T lymphocytes but not thymocytes provide a latent viral reservoir in a simian immunodeficiency virus-Macaca nemestrina model of human immunodeficiency virus type 1-infected patients on highly active antiretroviral therapy. J Virol 2003, 77:4938-4949.
55. Shen A, Yang HC, Zhou Y, Chase AJ, Boyer JD, Zhang H, Margolick JB, Zink MC, Clements JE, Siliciano RF: Novel pathway for induction of latent virus from resting CD4(+) T cells in the simian immunodeficiency virus/macaque model of human immunodeficiency virus type 1 latency. J Virol 2007, 81:1660-1670.
56. Myers LE, McQuay LJ, Hollinger FB: Dilution assay statistics. J Clin Microbiol 1994, 32:732-739.
57. Archin NM, Espeseth A, Parker D, Cheema M, Hazuda D, Margolis DM: Expression of latent HIV induced by the potent HDAC inhibitor suberoylanilide hydroxamic acid. AIDS Res Hum Retroviruses 2009, 25:207-212.